ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas

Xu, Dahua; Cao, Meng; Wang, Bo; Bi, Xiaoman; Zhang, Haiying; Wu, Deng; Zhang, Chunrui; Xu, Jiankai; Xu, Zhizhou; Zheng, Dehua; Chen, Liyang; Li, Peihu; Wang, Hong; Liu, Yan*; Jiang, Hongyan*; Li, Kongning*哈尔滨医科大学; 海南医学院; y
2023DOI: 10.7150/thno.79874
1被引13阅读
引用收藏
分享

摘要

Background: Glioblastomas are the most common and malignant central nervous system (CNS) tumors that occupied a highly heterogeneous tumor microenvironment (TIME). Long noncoding RNAs (lncRNAs), whose expression can be modified by DNA methylation, are emerging as critical regulators in the immune system. However, knowledge about the epigenetic changes in lncRNAs and their contribution to the immune heterogeneity of glioma is still lacking.Methods: In this study, we integrated paired methylome and transcriptome datasets of glioblastomas and identified 2 robust immune subtypes based on lncRNA methylation features. The immune characteristics of glioma subtypes were compared. Furthermore, immune-related lncRNAs were identified and their relationships with immune evasion were evaluated.Results: Glioma immunophenotypes exhibited distinct immune-related characteristics as well as clinical and epigenetic features. 149 epigenetically regulated (ER) lncRNAs were recognized that possessed inverse variation in epigenetic and transcriptional levels between glioma subtypes. Immune-related lncRNAs were further identified through the investigation of their correlation with immune cell infiltrations and immune-related pathways. In particular, the 'Hot' glioma subtype with higher immunoactivity while a worse survival outcome was found to character immune evasion features. We finally prioritized candidate ER lncRNAs associated with immune evasion markers and response to glioma immunotherapy. Among them, CD109-AS1 and LINC02447 were validated as novel immunoevasive biomarkers for glioma through in vitro experiments. Conclusion: In summary, our study systematically reveals the crosstalk among DNA methylation, lncRNA, and immune regulation in glioblastomas, and will facilitate the development of epigenetic immunotherapy approaches.

学科与关键词

关键词
glioblastomasDNA methylationlong non-coding RNAscancer subtypesimmune microenvironment
相关
加载中…
  • Genome‑wide DNA methylation regulation analysis of long non‑coding RNAs in glioblastoma.
    Ji, Jianghuai; Zhao, Lei; Zhao, Xiaoxiao; Li, Qianpeng; An, Yi; Li, Li; Li, DongguoInternational Journal of Molecular Medicine, 2020, 46(1): 224-238.
  • Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs
    Li, Yongsheng; Xu, Sicong; Xu, Dahua; Pan, Tao; Guo, Jing; Gu, Shuo; Lin, Qiuyu; Li, Xia*; Li, Kongning*; Xiang, Wei*Frontiers in Immunology, 2022, 13: 853904.被引 4
  • Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for glioma
    Huang, Fanxuan; Wang, Xinyu; Zhong, Junzhe; Chen, Hao; Song, Dan; Xu, Tianye; Tian, Kaifu; Sun, Penggang; Sun, Nan; Qin, Jie; Song, Yu; Ma, Wenbin; Liu, Yuxiang; Yu, Daohan; Meng, Xiangqi; Jiang, Chuanlu; Xuan, Hanwen; Qian, Da*; Cai, Jinquan*Cancer Cell International, 2023, 23(1): 156.
查看全部 →

发表信息

论文状态
公开发表
发表日期
2023
卷期
第 13 卷, 第 5 期
页码
1490-1505
DOI
10.7150/thno.79874
语言
ENGLISH
成果收录
SCIE
资助标注
Major Science and Technology Program of Hainan Province [ZDKJ202 1040, ZDKJ202003]; Hainan Province Science and Technology special fund [ZDYF2021SHFZ097]; National Natural Science Foundation of China [32160152]; Hainan Provincial Natural Science Foundation of China [820RC637, 822QN462]; Key Laboratory of Tropical Cardiovascular Diseases Research of Hainan Province [KLTCDR-202103]; Postdoctoral Science Foundation of Hainan Province, Bioinformatics for Major Diseases Science Innovation Group of Hainan Medical University

作者

  • X

    Xu, Dahua (第一作者)

    hainan med univ

  • C

    Cao, Meng

    hainan med univ

查看全部 16 位作者收起作者
  • W

    Wang, Bo

    hainan med univ

  • B

    Bi, Xiaoman

    hainan med univ

  • Z

    Zhang, Haiying

    hainan med univ

  • W

    Wu, Deng

    chinese univ hong kong

  • Z

    Zhang, Chunrui

    chinese acad sci, inst genet & dev biol

  • X

    Xu, Jiankai

    harbin med univ

  • X

    Xu, Zhizhou

    hainan med univ

  • Z

    Zheng, Dehua

    hainan med univ

  • C

    Chen, Liyang

    hainan med univ

  • L

    Li, Peihu

    hainan med univ

  • W

    Wang, Hong

    hainan med univ

  • L

    Liu, Yan (通讯)

    hainan med univ

  • J

    Jiang, Hongyan (通讯)

    hainan med univ

  • L

    Li, Kongning (通讯)

    hainan med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417